Literature DB >> 20413964

Editorial perspective. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?

Matthew R Weir1, George L Bakris.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20413964     DOI： 10.1159/000292500

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN： 0250-8095            Impact factor:   3.754


× No keyword cloud information.
  10 in total

Review 1.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

2.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

Review 3.  Proteomics and systems biology for understanding diabetic nephropathy.

Authors:  Jonathan M Starkey; Ronald G Tilton
Journal:  J Cardiovasc Transl Res       Date:  2012-05-12       Impact factor: 4.132

4.  Discovery and verification of urinary peptides in type 2 diabetes mellitus with kidney injury.

Authors:  Guangzhen Fu; Ye Du; Lina Chu; Man Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-03

5.  MRC2 Promotes Proliferation and Inhibits Apoptosis of Diabetic Nephropathy.

Authors:  Lanlan Li; Xin Chen; Henglu Zhang; Min Wang; Weiping Lu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-04-28       Impact factor: 2.916

6.  Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial.

Authors:  Arjan van der Tol; Wim Van Biesen; Francis Verbeke; Guy De Groote; Frans Vermeiren; Kathleen Eeckhaut; Raymond Vanholder
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

Review 7.  Diabetic nephropathy: Time to withhold development and progression - A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2017-04-21       Impact factor: 10.479

Review 8.  Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Authors:  Jay S Skyler; George L Bakris; Ezio Bonifacio; Tamara Darsow; Robert H Eckel; Leif Groop; Per-Henrik Groop; Yehuda Handelsman; Richard A Insel; Chantal Mathieu; Allison T McElvaine; Jerry P Palmer; Alberto Pugliese; Desmond A Schatz; Jay M Sosenko; John P H Wilding; Robert E Ratner
Journal:  Diabetes       Date:  2016-12-15       Impact factor: 9.461

9.  Role of Microalbuminuria and Hypoalbuminemia as Outcome Predictors in Critically Ill Patients.

Authors:  Mahmoud Nour; Abdelhaleem Hegazy; Abeer Mosbah; Ahmed Abdelaziz; Mohamed Fawzy
Journal:  Crit Care Res Pract       Date:  2021-04-12

10.  Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.

Authors:  Denis Delić; Claudia Eisele; Ramona Schmid; Patrick Baum; Franziska Wiech; Martin Gerl; Heike Zimdahl; Steven S Pullen; Richard Urquhart
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.